50

Makers Laboratories LtdBOM 506919

Последний отчетный период 30 сент., 2023

Обновлено 19 сент., 2024

Последняя цена

Капитализация млрд. $

0.005

Micro

Биржа

XBOM - Bombay Stock Exchange

Анализ акций 506919.BO

50

Нет оценки

Количественный анализ Eyestock не покрывает акции Makers Laboratories Ltd.

Капитализация млрд. $

0.005

Дивидендная доходность

2.50 %

Оборот

5.9 млрд

Сайт компании

https://www.makerslabs.com/

Makers Laboratories Ltd. is a pharmaceutical company, which engages in manufacturing and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 121 full-time employees. The firm is engaged in the manufacturing and marketing of pharmaceuticals. The firm operates through the pharmaceuticals segment. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range) and Exylin (Amoxycillin range). Its Inspira retail packs division includes acid regulatory (PPIS), anthelmintics, anti-allergic, anti-asthmatic, anti-biotics, anti-diabetics, anti-diarrheal, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensives, and others. Its Experia bulk packs division includes amoxycillin 250 mg capsules, betamethasone 0.5 mg tablets, cetirizine HCL 10 mg tablets, chloramphenicol capsules 250 mg, chloroquine phosphate 250 mg tablets, chlorpheniramine maleate 4 mg tablets, ciprofloxacin hydrochloride 250 mg tablets, and others.

Смотреть Секцию: Рейтинг